BioCentury
ARTICLE | Clinical News

Michael Becker, patient advocate and biotech exec, dies at 50

July 10, 2019 6:09 PM UTC

Michael Becker, a former biotech entrepreneur and author who became a fierce patient advocate in his final years, passed away from metastatic HPV-related cancer. He was 50.

Becker was president, CEO, CFO and director for several publicly traded biotechnology companies, including cancer companies Cytogen Corp. (acquired by EUSA Pharma Inc.) and VioQuest Pharmaceuticals Inc. and neurology company Relmada Therapeutics Inc. He was also president and founder of advisory firm MDB Communications LLC...